Prospective Assessment of Vesical Imaging-Reporting and Data System (VI-RADS) and Clinical Implications on Management of High-risk Non-muscle Invasive Bladder Cancers (NMIBCs) Candidate for Second Transurethral Resection (Re-TURBT)
cun id:
2374
UROLOGIA
RUOLO DELLA SINDROME METABOLICA NELLE CARATTERISTICHE CLINICHE E RADIOLOGICHE DEI PAZIENTI CON CALCOLOSI RENALE.
RUOLO DELLA SINDROME METABOLICA NEGLI OUTCOMES CLINICI IN PAZIENTI AFFETTI DA CALCOLOSI RENALE SOTTOPOSTI A PROCEDURE ENDOUROLOGICHE
Contrast-enhanced ultrasound (CEUS) in the evaluation of small renal masses: feasibility and outcomes.
Evaluation of miR-210-3p contribution to the establishment and drug responsiveness of clear cell Renal Cell Carcinoma (ccRCC) and its relevance as potential biomarker for the metastatic progression.
Implementation of SelectMDx non-invasive urinary biomarker-based risk score in the pre-biopsy setting for prostate cancer detection: a prospective study.
Robot-Assisted Tumor Thrombectomy For Renal Cell Carcinoma With Level IV Intraatrial Tumor Thrombus: Surgical Technique And Preliminary Outcomes
Oncogenic aberrations in tumor samples from transurethral resection of the bladder as predictive biomarkers of Bacillus Calmette-Guérin efficacy in non-muscle invasive bladder cancer patients.
Co-expression of Programmed Death Ligand 1 (PD-L1) and markers of Epithelial-Mesenchymal Transition (EMT) on Circulating Tumor Cells (CTCs): a possible immune escape mechanism in urothelial carcinomas of the urinary bladder.
Human papillomavirus infection and related diseases: a multidisciplinary approach.